Icaritin, a bioactive compound sourced from desiccated epimedium stems and leaves, dampens glycolytic processes mediated by GLUT1 in hepatocellular carcinoma (HCC) cells through the impediment of Janus kinase 2 (JAK2)/STAT3 pathway activation. Here, JAK2 is linked to hepatocellular carcinoma.